Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01671423 · ClinicalTrials.gov registry record · NA
Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis
A NA study of Cellulitis, sponsored by Albert Einstein Healthcare Network.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT01671423 is a NA study of Cellulitis that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 42 participants, below the 567-participant average among 11 other Cellulitis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01671423, a NA study of Cellulitis, has completed, sponsored by Albert Einstein Healthcare Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Cellulitis is the medical term for an infection of the skin, with symptoms including redness, swelling, warmth, and pain. This group of symptoms is called inflammation, and is caused by the body's immune system responding to the infection. Standard care for cellulitis is using antibiotics to destroy the infection, but the inflammation can persist and cause a great deal of pain. The hypothesis of this study is that adding a single dose of an oral steroid (prednisone), which tempers the immune response, will reduce inflammation, reduce pain, and speed recovery. This hypothesis will be examined by recruiting a group of patients with cellulitis, and randomizing them to two sub-groups: one group will receive a dose of prednisone, while the other group will receive a placebo. Neither group will know what they received unless there is a problem. These subjects will be followed up at the 48 hour mark and the 7 day mark, and will have their results compared.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Prednisone
Study Locations (1)
Pennsylvania
- Albert Einstein Medical Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01671423
The ClinicalTrials.gov registry entry for NCT01671423 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 567-participant average among 11 other Cellulitis trials with a reported enrollment target (93% lower). The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cellulitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01671423 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01671423 about?
NCT01671423 is a clinical study titled "Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis". Cellulitis is the medical term for an infection of the skin, with symptoms including redness, swelling, warmth, and pain. This group of symptoms is called inflammation, and is caused by the body's immune system responding to the infection. Standard care for cellulitis is using antibiotics to destroy...
What is the current status of trial NCT01671423?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2012-08. Estimated completion is 2015-09.
What conditions does trial NCT01671423 study?
This clinical trial studies the following conditions: Cellulitis.
What interventions are being tested in trial NCT01671423?
The interventions under investigation include: Placebo (DRUG), Prednisone (DRUG).
Who is sponsoring clinical trial NCT01671423?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01671423 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cellulitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care
COMPLETED · NA
-
Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage
COMPLETED · Phase 2
-
Utility of Thermal Imaging in Diagnosis of Cellulitis for Lower Extremity Complaints in the Emergency Department
COMPLETED
-
Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
COMPLETED · Phase 4
-
Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.